| # | % | |||||
|---|---|---|---|---|---|---|
| 401 | BERKLEY W R CORP | 9,000 | 539,000 | 0.01% | ||
| 402 | CNO FINL GROUP INC | 30,000 | 524,000 | 0.00% | ||
| 403 | BIOLINERX LTD | 611,947 | 490,000 | 0.00% | ||
| 404 | AEGLEA BIOTHERAPEUTICS INC | 100,000 | 486,000 | 0.00% | ||
| 405 | INSTALLED BLDG PRODS INC COM | 12,269 | 445,000 | 0.00% | ||
| 406 | MINDBODY INCORPORATED COM CLASS A | 25,000 | 404,000 | 0.00% | ||
| 407 | WILSHIRE BANCORP INC | 37,812 | 394,000 | 0.00% | ||
| 408 | BIOAMBER INC | 131,009 | 390,000 | 0.00% | Call | |
| 409 | RLJ ENTMT INC | 200,000 | 390,000 | 0.00% | Call | |
| 410 | VASCULAR BIOGENICS LTD | 83,333 | 384,000 | 0.00% | Call | |
| 411 | WINDTREE THERAPEUTICS INC | 178,570 | 345,000 | 0.00% | Call | |
| 412 | Nivalis Therapeutics Inc | 67,408 | 310,000 | 0.00% | ||
| 413 | CTI BIOPHARMA | 789,487 | 268,000 | 0.00% | ||
| 414 | BELLEROPHON THERAPEUTICS INC | 146,969 | 260,000 | 0.00% | ||
| 415 | NEOVASC INC | 489,026 | 252,000 | 0.00% | ||
| 416 | PARNELL PHARMACEUTICALS HOLDINGS LTD | 147,458 | 240,000 | 0.00% | ||
| 417 | Carbylan Therapeutics Inc. | 154,830 | 103,000 | 0.00% | ||
| 418 | GEVO INC | 97,040 | 57,000 | 0.00% | Call | |
| 419 | TRANSITION THERAPEUTICS INC | 38,285 | 56,000 | 0.00% | ||
| 420 | BIND THERAPEUTICS INC | 114,786 | 45,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-16-000288, filed 2016.08.15), New Holdings filing (0001164691-17-000149, filed 2017.08.17), New Holdings filing (0001164691-17-000112, filed 2017.05.17), New Holdings filing (0001453072-17-000030, filed 2017.02.17). and New Holdings filing (0001164691-16-000327, filed 2016.11.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
